Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2014 | 07-2014 | 04-2014 | 01-2014 | 10-2013 | |
| Sales | 1,882 | 1,912 | 2,457 | 3,690 | 2,383 |
| Cost of Goods | 1,719 | 1,722 | 1,540 | 1,622 | 1,430 |
| Gross Profit | 163 | 190 | 917 | 2,068 | 953 |
| Operating Expenses | 4,548 | 4,641 | 3,842 | 4,098 | 3,084 |
| Operating Income | -3,666 | -3,729 | -2,385 | -1,408 | -1,701 |
| Other Income | 598 | 186 | 109 | 839 | -614 |
| Pre-tax Income | -3,068 | -3,543 | -2,276 | -569 | -2,315 |
| Income Tax | 10 | 5 | 6 | 5 | 3 |
| Net Income Continuous | -3,078 | -3,548 | -2,282 | -574 | -2,318 |
| Net Income | $-3,078 | $-3,548 | $-2,282 | $-574 | $-2,318 |
| EPS Basic Total Ops | -0.55 | -0.64 | -0.48 | -0.12 | -0.36 |
| EPS Basic Continuous Ops | -0.55 | -0.64 | -0.41 | -0.10 | -0.42 |
| EPS Diluted Total Ops | -0.65 | -0.64 | -0.36 | -0.24 | -0.36 |
| EPS Diluted Continuous Ops | -0.54 | -0.61 | -0.41 | -0.10 | -0.42 |
| EBITDA(a) | $-3,612 | $-3,673 | $-2,330 | $-1,352 | $-1,649 |